SMOKING CESSATION Flashcards

1
Q

The 5 A’s Approach to smoking cessation

A

– Five-step framework that serves as a guide to encourage patients to quit smoking – recommended in the national guidelines since 2008 Ask about tobacco use – ask in a way that you can identify various kinds and intermittent use

Advise quitting – Clear evidence that brief (<5 mins) at each encounter can make a difference

Assess readiness to quit – Focus conversations and actions based on readiness ‘stage’

Assist smokers ready to quit – Create plan, provide support, recommend pharmacotherapy

Arrange follow-up – Ideally within 1-2 weeks of agreed upon quit date

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Proactive approach for smoking cessation

A

Offering in a positive way rather than promoting it as optional – increases likelihood they will at least try the treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 types of pharmacotherapies for smoking cessation

A

1) nicotine replacement therapy
2) varenicline (chantix)
3) buproprion (zyban)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

nicotine replacement therapy (NRT)

A
  • Multiple dosage forms available to suit the patient’s needs
  • Patches, gum, lozenge, inhalers, and nasal spray
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Varenicline (chantix)

How does it work?

Route?

A

Modulates the mesolimbic dopamine system associated with nicotine addiction

Oral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Buproprion (zyban)

How does it work?

A

inhibits the reuptake of dopamine- stimulates the “reward” system of the brain and curbs cravings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA of nicotine

A

1) agonist at the nicotine receptors - two main effects are believed to be positive properties
a) reward effect is exerted in the limbic system
b) stimulating effect is exerted in the coortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ADR of nicotine therapy

A

1) HA
2) dyspepsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nicotine metabolism and excretion

A

1) it is cleared by hepatic and renal system so consider dose adjustments in someone with ESRD or hepatic impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nicotine patches dosing

A

1) 21 mg for >10 cigarettes/ day
2) 14 mg for 10 or fewer
3) 7 mg for titration down or tolerability issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adminsitration of nicotine patches

A

1) apply one patch daily *can remove in the evenings for insomnia, vivid dreams or other ADRs
2) MAY START THE PATCH BEFORE THE QUIT DATE
3) rotate the application site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advantages of nicotine patch

A

1) ease of use
2) steady nicotine levels
3) OTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

disadvantage of nicotine patches

A

1) can’t alter nicotine levels in case of cravings
2) takes up to 3 hours to reach peak effect when applied (if removed for nighttime can be problematic in morning)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nicotine gum Dosing

A

1) 2 mg if the first cigarette is >30 minutes after waking
2) 4 mg if first cigarette is <30 min after waking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nicotine gym administration

A

1) chew 1 piece every hour prn (24 pieces per day)
2) no food or drink for 30 min before or during use
3) chew slowly until it tingles, then park the gum between check and gum until tingle is gone- repeat until tingling no longer happens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Advantages of nicotine gum

A

1) user controls nicotine dose
2) oral sensation- good substitute for cigarettes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Disadvantages of nicotine gum

A

1) unpleasant taste, mouth irritation, jaw soreness, heartburn, nausea, hiccups
2) potentially damaging to dental work
3) difficult for those with dentures

18
Q

Nicotine Lozenge dosing

A

1) 2 mg if first cigarette is >30 min after waking
2) 4 mg if first cigarette is < 30 minutes before or during use

19
Q

Advantage of nicotine lozenges

A

1) user controls nicotine dose
2) oral sensation - good substitute for cigarettes
3) can be used by smokers with poor dentition or dentures

20
Q

Disadvantage of nicotine Lozenge

A

1) unpleasant taste
2) mouth irritation
3) hiccups
4) heart burn or nausea

21
Q

Nicotine Inhaler Dosing

A

10 mg catridge

22
Q

Administration of nicotine inhaler

A

1) inhaler 1 cartridge every 1-2 hours prn (max 16 catridges / day)
2) do NOT inhale like a cigarette into lungs - deeply inhale in the back of the throat or puff in short breaths- lasts about 20 min with active puffing

23
Q

Advantages of the nicotine inhaler

A

1) user controls the nicotine dose
2) oral sensation- good substitute for cigs

24
Q

Disadvantages of nicotine inhaler

A

1) visible when being used (social aspect)
2) caution in reactive airway diseases (COPD/asthma)
3) mouth/throat irritation

25
Q

Nicotine nasal spray dosing

A

0.5 mg per spray

26
Q

Nicotine nasal spray administration

A

apply 1 spray to each nostril every 1 - 2 hours prn (may 10 sprays/ hours, 80 sprays/ day)

27
Q

advantages of nicotine nasal spray

A

1) user controls nicotine dose
2) most rapid delivery of nicotine amongst NRT products

28
Q

Disadvantage of nicotine nasal spray

A

1) localized irritation to the nasal mucosa- poor tolerability long term
2) nasal/throat irritation along with coughing, sneezing, and teary eyes

29
Q

Vareniclne indications

A

smoking cessation

30
Q

moa of varenicline

A

1) partial agonist at alpha 4, beta 2 nicotinic receptors- prevents nicotine stimulation of mesolimbic dopamine system a/w nicotine addiction
a) partial agonism stimulates SOME dopamine activity, but to a much smaller degree than nicotine
b) decreases cravings and withdrawal sxs

31
Q

Route of varenicline

A

oral tablets
- starter pack and continuing packs- 7 day titration in starter pack

32
Q

ADR of varenicline

A

1) abnormal dreams,
2) SLEEPWALKING

3) harmful behaviors
4) n/v
5) DEPRESSION, SI and behaviors
6) seizures

33
Q

Buproprion SR Indications

A

smoking cessation

34
Q

Buproprion SR US box warrnings

A

suicide risk- increases the risk of suicidal thoughts and behaviors in pediatric, adolescent or young adult patients

35
Q

MOA of buproprion SR

A

dopamine and norepinephrine reuptake inhibitor- increases amount of dopamine available for stimulation of dopamine receptors
-stimulates the reward system and curves cravings

36
Q

Contraindications for buproprion

A

1) seizures
2) hx of anorexia
3) pts undergoing abrupt d/c of ethanol or sedatives (seizures risk)
4) use of MAOIs concomitantly or within the last 14 days

37
Q

ADR of buproprion SR

A

1) tachycardia and diaphoresis
2) weight loss
3) GI disturbances
4) agitation, dizziness, insomnia, migraines, tremors, blurred vision

38
Q

benefit of buproprion sr

A

good agent for someone with untreated depression - 2 birds with one stone

39
Q

how to choose therapy selection for smoking cessation

A

1) largely based on patient preference with a few notable exceptions for contraindications/ tolerability
2) typically for NRT, two agents are suggested for initial therapy- patch (long acting) and some form of short acting for cravings
3) varenicline and NRT is an option too- additive nausea and sleep disturbances can be bothersome
4) bupropian appears to be somewhat less effective in clinical trails so is typically NOT first line

  • may be first liine in a patient with UNTREATED depression
    • tends to be the least expensive as well
40
Q

Follow up for smoking cessation

A
  1. focus on reinforcement of quitting, monitor response to smoking cessation, optimize treatment with first-line therapies, monitor for adverse effects
  2. additionally, address any problems that develop as a result of smoking cessation- weight gain, depression, change in relationship statuses with those that still smoke
  3. relapse prevention and counseling - encourage continued total abstinence
  4. consider weening pharmacotherapy after 3-6 months - careful attention to check for relapse - one meta analysis indicated continued pharmacotherapy for 18 months help prevent relapse